Top

News & Events

Client News

Client News Our News Insights Features

21 December 2017
Immatics Proprietary Target Selected for the Development of Cancer Immunotherapies

19 December 2017
Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market

18 December 2017
Autifony Therapeutics and Boehringer Ingelheim collaborate on a novel therapeutic approach to a range of CNS disorders

14 December 2017
Dimerix and Proteomics Partner to Improve Treatment of Chronic Kidney Disease

14 December 2017
Seventure Partners’ Microbiome Portfolio is Reaching Critical Milestones in Current and Upcoming Clinical Trials

12 December 2017
Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients

12 December 2017
Forbion leads €25 million Series A fundraising in NorthSea Therapeutics and its promising NASH drug programme

12 December 2017
NorthSea Therapeutics secures €25 million funding for clinical development of promising NASH drug

12 December 2017
Abzena Half year results: Growth strategy progressing

11 December 2017
Abzena secures contract for integrated ADC manufacturing services to US biotech company

11 December 2017
Hookipa Biotech Raises $60 million (€50 million) in an Oversubscribed Round C Financing

07 December 2017
Uptick in M&A Activity and Investor Cash Expected to Re-invigorate Pharma and Biotech in 2018

07 December 2017
OCON Medical’s Hormone-Free Contraceptive Ballerine® Significantly Reduces Uterine Pain and Bleeding

07 December 2017
Expert Review Panel for Diagnostics Approves Atomo HIV Self Test for Procurement by Unitaid and the Global Fund

07 December 2017
Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit Ahead of European Launch

07 December 2017
Cell Medica announces appointment of industry leader Dr Annalisa Jenkins as Chair

06 December 2017
Clinigen Plc: Directorate Change

05 December 2017
Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation Study

01 December 2017
SmithsonHill to Deliver £500 Million Park to Revolutionise Growing AgriTech Sector Globally

01 December 2017
Polyganics Awarded €1.2 million to Complete Clinical Development of Dura Sealant Patch

01 December 2017
SkinBioTherapeutics: Notification of First Patent Grant

30 November 2017
New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations

29 November 2017
Trod Medical Granted New Patent for its Encage™ Prostate Focal Therapy Device

28 November 2017
Dimerix to Present at the 2nd World Congress for Clinical Trials in Diabetes

28 November 2017
Agendia’s MammaPrint® Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code

28 November 2017
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

20 November 2017
AJCC Confirms MammaPrint’s Clinical Utility for Treatment Decisions and Staging in Recent 8th Edition Breast Chapter Update

20 November 2017
LiDia® BSI Test Demonstrates Rapid and Sensitive Identification of Bloodstream Infections Direct from Whole Blood Samples

16 November 2017
US FDA Grants Qualified Infectious Disease Product Designation for RECCE® 327

16 November 2017
Mission Therapeutics’ Highlights Positive Parkinson’s Disease USP30 Target and Inhibitor Data at the Society for Neuroscience 2017 Annual Meeting

14 November 2017
Novel antibodies against a ground-breaking new target for the treatment of Cardiovascular Fibrosis developed by Enleofen Bio, with support from Abzena, featured in ‘Nature’ article

10 November 2017
Seventure Partners Announces the Trade Sale of its Portfolio Company Cambrooke Therapeutics Inc. to Ajinomoto Co. Inc

09 November 2017
SkinBiotix® platform passes additional external toxicity tests

07 November 2017
DNAe to Present New Data on LiDia™ BSI, its rapid blood-to-result diagnostic test at the Association of Molecular Pathology Annual Meeting

02 November 2017
Dimerix Presents Detailed Subgroup Analysis from DMX-200 Phase 2a Trial in Chronic Kidney Disease Showing Compelling Efficacy Signals in Diabetic Nephropathy Patients

01 November 2017
Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients with Solid Tumours

01 November 2017
e-Therapeutics: Appointment of Director

31 October 2017
BioGeneration Ventures Fund III reaches EUR 82 million in final close: Investments from Bristol-Myers Squibb and Johnson & Johnson Innovation - JJDC

30 October 2017
Mission Therapeutics Presenting at The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Conference

30 October 2017
BioScience Managers Expands Team, Adding Significant New International Expertise

26 October 2017
New Study Published in JAMA Oncology Shows MammaPrint® Changed Breast Cancer Treatment Decisions in 3 out of 4 Cases where Guidance was Unclear with the 21-Gene Assay

25 October 2017
Microbiotica to Participate in Microbiome Panel at BIO-Europe®

24 October 2017
Dimerix Receives Ethics Committee Approval in Australia for Pharmacokinetic Trial of New Extended Release Formulation

24 October 2017
Dr. Istvan Udvaros joins Cristal Therapeutics as New Chief Medical Officer

23 October 2017
Clinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines

20 October 2017
Auspherix Presents Pharmacokinetic-Pharmacodynamic (PK/PD) Profile of its Antibacterial Compounds in Rodents

19 October 2017
Abzena and UGA Biopharma partner to develop a cell line expressing a biosimilar therapeutic for Multiple Sclerosis

18 October 2017
Dimerix Appoints Medical Advisory Board in Readiness for Phase 2b Trials

18 October 2017
Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors

11 October 2017
Microbiotica Celebrates Successful First Year with Third Award Win

11 October 2017
Xellia Pharmaceuticals Expands its Global Specialty Anti-infective Product Manufacturing Capabilities with a US$25m Investment in its Copenhagen Site

10 October 2017
Adherium Wins 2017 OBN Award for Best Implementation of Digital Healthcare

10 October 2017
CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics gives access to safe, accurate and reliable self-testing

09 October 2017
Breast Cancer is the Most Feared Cancer Among Women in Germany, Although Less than Half are Aware of the Benefits of Genomic Testing

06 October 2017
Instinctif Partners Life Sciences Congratulates the Winners of the OBN Awards 2017

06 October 2017
Regulatory Approval in Europe Granted for Synthon’s Glatiramer Acetate 40 mg/ml

05 October 2017
SkinBioTherapeutics plc: Full year results

04 October 2017
Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

03 October 2017
SkinBioTherapeutics: SkinBiotix® platform passes external cytotoxicity tests

02 October 2017
PnuVax awarded $29.4 million USD grant to advance innovative vaccine into clinical trials

29 September 2017
Mission Therapeutics’ Scientists Highlight Significance of Deubiquitylating Enzymes (DUBs) as Key Drug Targets

28 September 2017
LNC Therapeutics raises €6.5m and reinforces its R&D in the Microbiota field

28 September 2017
Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine® Approach in Patients with Advanced Solid Cancers

28 September 2017
Clinigen Group plc: Strong Performance With Adjusted EPS Up 25%

27 September 2017
Breast Cancer – Let’s Make It Personal: Agendia Supports Breast Cancer Awareness Month with International Program of Activities

26 September 2017
DNAe Previews its Semiconductor Genomic Analysis Test to Address the Challenge of Sepsis

26 September 2017
e-Therapeutics plc: Interim Results for the 6 Months Ended 31 July 2017

25 September 2017
Clinigen and Cumberland launch Totect® in the U.S.

25 September 2017
Worldwide Medtech Sales Forecast to Reach $522 Billion by 2022 with a CAGR of 5.1% between 2016 and 2022

20 September 2017
Capital Cell, Europe’s First Dedicated Life Sciences Crowdfunding Platform, Opens to UK investors

19 September 2017
Adherium Appoints New CFO

19 September 2017
Abzena appoints Lotta Ljungqvist as Non-Executive Director

19 September 2017
Moncef Slaoui joins Medicxi

19 September 2017
Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions

18 September 2017
Microbiotica Wins Biotech and Money’s ‘Life Science Spin-out of the Year’

18 September 2017
Microbiotica to Present at Leading Microbiome Summit

18 September 2017
Health for Life Capital™ Participates in $35m Series B Financing of Visionary Food Science Company MycoTechnology Inc

18 September 2017
Cell Medica appoints CSO to accelerate R&D for CAR and TCR programmes

18 September 2017
Karus Therapeutics Announces First Cancer Patients Dosed with KA2507, a Small Molecule HDAC6-Selective Inhibitor, in a Phase I Clinical Trial

14 September 2017
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain

13 September 2017
European Patent Office Decides in Synthon’s Favor in Glatiramer Patent Case

13 September 2017
DNAe Presents Pipeline of Rapid Diagnostic Tests Set to Bring Next Generation Sequencing Closer to the Clinical Point-Of-Need

13 September 2017
Invicro Acquires Imanova to Expand Global Imaging Capabilities

13 September 2017
10-Year Prospective Outcome Data and MINDACT Sub-Study Presented at ESMO Congress Demonstrate Prognostic Value of MammaPrint® in Personalizing Early-Stage Breast Cancer Treatment

13 September 2017
Recommended Acquisition Of Quantum Pharma plc by Clinigen Group plc

12 September 2017
Scientists Present Positive Progress in the Development of a New Class of Broad-Spectrum Organogold Antibiotics to Address Antibiotic-Resistant Bacterial Infections

12 September 2017
Adherium Releases Next Generation Adherence Monitor, SmartTurbo Model 4, for AstraZeneca’s Turbuhaler

07 September 2017
Recce Confirms Pre-IND Data Submission to US FDA for its Lead Antibiotic Candidate

06 September 2017
Congenica’s Sapientia™ selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project

05 September 2017
DNAe to Present its NGS Diagnostics Pipeline at 24th Annual Newsmakers in the Biotech Industry

05 September 2017
Dimerix Announces DMX-200 Tablet Manufacture and Human Pharmacokinetic Study Timeline

01 September 2017
Adherium Receives U.S. 510(K) Clearance for Next Generation Smartinhaler for AstraZeneca’s Symbicort Aerosol Inhaler

31 August 2017
Adherium Exhibiting at 27th International Congress of the European Respiratory Society

31 August 2017
Imugene Commences First Patient Dosing of HER-Vaxx

22 August 2017
Xellia Pharmaceuticals Completes Expansion of its Budapest Facilities, Strengthening its Global Anti-infective Product Capabilities

21 August 2017
Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

18 August 2017
Adherium Hits 100,000 Smartinhaler™ Commercial Milestone

16 August 2017
Dimerix to Present Analysis of DMX-200 Phase 2a Clinical Trial in Chronic Kidney Disease at the American Society of Nephrology (ASN) Annual Kidney Week 2017

08 August 2017
Clinigen Receives EC Approval for Updates to Cardioxane Product Information

03 August 2017
Biopharma Stages a Strong Recovery Over the First Half Even as M&A deals Disappoint, While Unprecedented Amounts of Money Flow in Medtech but Not Towards Smaller Innovators

01 August 2017
Japanese Pharmaceutical Market Set to Grow 3.3% (CAGR) Between 2017 and 2022, Significantly Lower than the Worldwide Outlook (6.5% CAGR)

31 July 2017
Recce Confirms Delivery by Intravenous Drip for its RECCE® 327 Antibiotic, with FDA IND Submission on Track

31 July 2017
BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support BioScience Managers’ and Downing’s Life Sciences Investments

24 July 2017
e-Therapeutics Announces Outcome of Strategic Review and Future Plans

20 July 2017
Epi Analyzer: Blockbusters Out, Highly Targeted Therapies In

20 July 2017
Recce achieves milestone with volume production of antibiotic compounds to support clinical trials

19 July 2017
Clinigen and Sarepta Therapeutics launch a Managed Access Program to treat patients with Duchenne Muscular Dystrophy amenable to exon 51 skipping

18 July 2017
Abzena and Telix sign licence agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

18 July 2017
Clinigen Group plc: Year end trading update 2017

12 July 2017
Rapid, Near-patient Genomic Tests for Infectious Disease set to Revolutionize Antibiotic Prescribing and Patient Care

12 July 2017
Dimerix Reports Positive Results from Phase 2a Trial of DMX-200 in Chronic Kidney Disease

11 July 2017
Health for Life Capital™ Participates in Financing of Two Connected Health companies: Machtfit in Germany and Push Doctor in the UK

11 July 2017
Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data

11 July 2017
Abzena and OBI Pharma sign ThioBridge™ licence agreement

10 July 2017
Clinigen and Cumberland Pharmaceuticals obtain FDA approval for Totect® in the U.S.

10 July 2017
Autifony Therapeutics receives Orphan Drug Designation for AUT00206 for Fragile X Syndrome

06 July 2017
Agendia’s MammaPrint® recommended by the 2017 St. Gallen International Breast Cancer Guidelines in significant update

05 July 2017
Health for Life Capital™ Participates in $13.2m Financing of Japanese Microbiome Leader Anaeropharma Science

29 June 2017
MammaPrint® Late Recurrence (20yr) Low Risk result identifies breast cancer patients with 97% survival at 20-years with limited endocrine therapy treatment

27 June 2017
Health for Life Capital™ Further Expands Israeli Portfolio with Investment in Microbiome App Developer

27 June 2017
Mission Therapeutics Appoints Scientific Advisory Board

27 June 2017
BioGeneration Ventures Fund III Secures EUR 66m, exceeding EUR 50m target

26 June 2017
Microbiotica Shortlisted for Biotech and Money’s ‘Life Science Spin-out of the Year’

26 June 2017
Abcam announces first international Epigenetics conference in South Korea

22 June 2017
Clinigen signs exclusive supply agreements in Global Access

22 June 2017
Recce Constructs Automated Manufacturing Facility to Support Clinical Trials

21 June 2017
Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform

20 June 2017
Microbiotica to Present at Microbiome Drug Development Summit

20 June 2017
Cell Medica acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult

16 June 2017
Recce Secures up to A$6.05 Million Investment Agreement with US Institutional Investor

15 June 2017
LifeArc set to transform medical research landscape

15 June 2017
Medicxi launches first $300m late-stage life sciences fund Medicxi Growth 1 (MG1), backed by Novartis and Verily

14 June 2017
Crescendo Biologics Appoints Edward J. Stewart as Chief Business Officer

13 June 2017
Three New Studies Presented at ASCO Annual Meeting Demonstrate Benefits of MammaPrint® in Aiding Individualized Treatment Management for Early-Stage Breast Cancer Patients

13 June 2017
Full year results: integration and growth seen across the Group, with 41% underlying increase in revenues

13 June 2017
‘Microbes and Me’ - how our understanding of the microbiome is pushing new horizons in research and spawning a US$0.5bn+ industry

13 June 2017
Research published in Scientific Reports uses state-of-the-art CRISPR technology to validate relevance of the Dimerix Receptor-HIT technology in real time

09 June 2017
Adherium Appoints New CEO to Drive Global Growth

06 June 2017
Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease

05 June 2017
F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology

01 June 2017
The PD-1 / PD-L1 Combination Therapies Revolution: New EP Vantage Report Sees Immuno-oncology Trials Triple and Keytruda Steal the Crown from Opdivo

30 May 2017
Atomo Diagnostics’ HIV Self Test receives approval from Kenya Ministry of Health

26 May 2017
Hookipa Biotech Announces Nature Communications Publication Showing TheraT® Turns Cold Tumors Hot

24 May 2017
Bioverativ to acquire True North Therapeutics and the Abzena Inside portfolio product, TNT009

23 May 2017
SkinBioTherapeutics: Extension of research contract with University of Manchester

22 May 2017
Clinigen achieves positive CHMP opinion concerning Cardioxane in Europe

19 May 2017
Recce moves closer to clinical study application with additional data on its novel antibiotic

18 May 2017
DNAe’s Semiconductor DNA Analysis Technology Featured in Nature’s Scientific Reports’ Top 100 Most Read Papers of 2016

18 May 2017
Health for Life Capital™ Expands Portfolio into Israel, Invests in Microbiome Therapeutics Company BiomX

18 May 2017
Autifony Therapeutics initiates recruitment into schizophrenia clinical trial for first-in-class drug

16 May 2017
Flexible Amersham™ Typhoon™ NIR Plus Biomolecular Imager for near-infrared multiplex detection

16 May 2017
Seventure Partners Life Sciences, Microbiome Investing Update for January – May 2017

11 May 2017
Clinigen and TESARO partner to initiate European Managed Access Program for niraparib for patients with recurrent ovarian cancer

08 May 2017
Lonza Poster detailing i-body expression in yeast

04 May 2017
Hookipa Biotech presents positive data from Phase 1 first-in-human trial of vaccine against cytomegalovirus

02 May 2017
Agendia’s MammaPrint® Now Included in First Coast Coverage for Medicare Breast Cancer Patients in Florida, Puerto Rico and the Virgin Islands

27 April 2017
Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet

27 April 2017
Adherium presents its Smartinhaler™ data at Respiratory Drug Delivery Europe 2017

26 April 2017
Abzena to pursue $12 million investment program to upgrade and expand its San Diego biomanufacturing operations

26 April 2017
Abzena to pursue $5 million investment program in Bristol

26 April 2017
AdAlta Quarterly Results and Cash Flow Statement

25 April 2017
Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)

20 April 2017
Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study

19 April 2017
Recce calls for Australian investment in R&D to develop new antibiotics on the back of initiatives

19 April 2017
Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech

12 April 2017
Agendia Appoints Patrick J. Balthrop Sr., Former CEO of Luminex, as Chairman

12 April 2017
Adherium to present at Respiratory Drug Delivery Europe 2017

11 April 2017
Mission Therapeutics and University of Oxford Awarded Research Grant from the Michael J. Fox Foundation

10 April 2017
Recce Ltd - Operational Update

10 April 2017
AdAlta - Research Report

06 April 2017
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor

06 April 2017
e-Therapeutics plc Appointment of Chief Executive Officer

05 April 2017
Abzena plc: Result of bookbuild

05 April 2017
SkinBioTherapeutics: First day of dealings

05 April 2017
Abzena plc: Proposed placing of £25 million

04 April 2017
Crescendo Biologics Appoints Philip Bland-Ward as Chief Scientific Officer

03 April 2017
Australia’s Bionic Vision Technologies Raises US$18 million (AU$23.5m) to Develop ‘Bionic Eye’ for Global Markets

03 April 2017
Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study

27 March 2017
Data from large animal study shows RECCE® 327 well tolerated

23 March 2017
Clinigen hosts Unlicensed Medicines satellite symposium at 22nd Congress of EAHP

21 March 2017
SkinBioTherapeutics intention to launch Initial Public Offering and list on AIM

21 March 2017
European Group on Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint® Test with Highest Level 1A Clinical Evidence

21 March 2017
AdAlta expands partnership with world-leading fibrosis research team at Melbourne’s The Alfred Hospital

20 March 2017
Auspherix to Present Organogold Pipeline at Superbugs & Superdrugs

20 March 2017
Mission Therapeutics Strengthens Senior Leadership Team with the Appointment of Dr Anne Phelan as Senior Vice President, Head of Discovery Research

16 March 2017
Cell Medica: £60 million Series C financing to advance multiple cancer programmes

16 March 2017
Innovations invests £13.7m in £60.0m funding round in Cell Medica

16 March 2017
Clinigen and Diurnal partner for European Managed Access programme for Infacort® and Chronocort®

15 March 2017
Patents licensed to Synthon relating to the CD47-SIRPα pathway resist challenges in the U.S. and Europe

15 March 2017
Autifony Therapeutics obtains £1.3 million in funding from Innovate UK and the Dementia Discovery Fund to explore novel approach to treatment of dementia

15 March 2017
Clinigen Group plc: STRONG H1 PERFORMANCE WITH ADJUSTED EPS UP 31%*

14 March 2017
Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval

10 March 2017
First-in-class Fycompa® (perampanel) approved in South Africa for partial-onset seizures

08 March 2017
German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence

07 March 2017
DNAe Appoints International Infectious Disease Experts to its Newly Formed Clinical Advisory Board

06 March 2017
‘Abzena inside’ product for neurodegenerative conditions moves into Phase II trial

06 March 2017
Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech

06 March 2017
Staten Biotechnology exercises option to develop therapeutic SIMPLE AntibodyTM for dyslipidemia from argenx N.V.

02 March 2017
Synthon enters worldwide exclusive license and collaboration with Sanquin for immuno-oncology therapeutic leads modulating the CD47-SIRPα pathway

01 March 2017
Abzena plc: Medical Research Council grant awarded to collaboration group developing novel autoimmune therapy

01 March 2017
Whatman™ EasiCollect™+ System for simple, reliable buccal sample collection and storage

28 February 2017
Median Cost Per Patient for Orphan Drugs is 5.5 Times Higher Than Non-Orphan Drugs

28 February 2017
Halaven® (eribulin) launches in South Africa for the treatment of women with advanced breast cancer

27 February 2017
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business

24 February 2017
Recce Releases Microscopy Images of its Synthetic Antibiotic in Action Destroying Bacteria

23 February 2017
AmpliPhi Biosciences Establishes Scientific Advisory Board and Appoints Dr. Timothy Lu of MIT and Broad Institute as SAB Chairman

23 February 2017
Recce to suspend anti-cancer program and focus on commercialising synthetic lead compound against resistant bacteria and viruses

22 February 2017
Funding of four initial projects and operational update

22 February 2017
DNAe announces opening of US facility, expansion of operations and launches product brand as it prepares for commercialization

21 February 2017
EP Vantage Releases its Annual Pharma and Medtech Sector Review Reports for 2016

21 February 2017
Innovations portfolio company Cell Medica granted FDA Fast Track designation for lead oncology product

21 February 2017
Lead cancer immunotherapy candidate receives FDA fast track designation

21 February 2017
Abzena plc: Antibody manufacturing development agreement signed with UCL

21 February 2017
Abzena plc: Trading and business update

16 February 2017
Polyganics’ “STOP NEUROMA” Study Interim Data Shows Reduction in Pain

10 February 2017
Asthma UK’s ‘Smart Asthma’ report highlights opportunity to improve asthma care through connected health

08 February 2017
Trod Medical Receives US Patent Allowance for Prostate Focal Therapy EncageTM Device

07 February 2017
Forbion Invests in Prexton Therapeutics’ EUR 29 million (USD 31 million) Series B Financing

07 February 2017
Atomo Diagnostics receives further international financing

06 February 2017
Ampliphi Biosciences to Present at the 19th Annual BIO CEO and Investor Conference

03 February 2017
UV-Cap GmbH & Co KG acquires Scil Proteins GmbH Scil Proteins GmbH becomes Navigo Proteins GmbH

02 February 2017
Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals

31 January 2017
Dimerix key patent allowed in Japan for use of lead drug candidate in the treatment of kidney disease

31 January 2017
AdAlta’s Q4 Statement – Delivering on Key Milestones and Progress of AD-114 Lead Fibrosis Product Towards the Clinic

30 January 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer

30 January 2017
Agendia Co-Founder Laura van ‘t Veer Wins European Cancer Organization Clinical Research Award

26 January 2017
Innovative Wellbeing Company Skinjay Receives €3.5M from Seventure Partner’s Health for Life Capital

25 January 2017
Evaluate: The Value of Outliers in Consensus Forecasting

25 January 2017
Dimerix Raises AU$2 million to Advance Clinical Program

25 January 2017
HY trading update: strong H1 performance with gross profit up 34%

20 January 2017
Abzena signs new ThioBridge™ licence agreement

18 January 2017
AdAlta receives Orphan Designation for its lead drug candidate targeting patients with idiopathic pulmonary disease

18 January 2017
Recce’s lead compound reduces illness in mice infected by resistant E. coli bacteria

18 January 2017
Xellia Pharmaceuticals Signs Davos Declaration on Combating Antimicrobial Resistance

17 January 2017
Clinigen initiates U.S. Managed Access program for TESARO’s niraparib for patients with ovarian cancer

11 January 2017
NICE acknowledges Smartinhaler™ technology can improve adherence to asthma medication

10 January 2017
Adherium appoints digital health pioneer to lead European business development

10 January 2017
Autifony Therapeutics announces positive results from Phase I study of AUT00206, a first-in-class Kv3 modulator for treatment of schizophrenia

09 January 2017
Clinigen and Cumberland Pharmaceuticals enter exclusive U.S. commercialisation agreement for Totect®

09 January 2017
Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave® as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections

09 January 2017
AdAlta Announces Positive Pre-clinical Data Showing Lead Drug Candidate Has Broad Fibrosis Treatment Potential

09 January 2017
Appointment of Amgen Executive Director as Chief Executive

06 January 2017
Seventure Partners Life Sciences, Microbiome Investing: Update for September – December 2016

05 January 2017
Auspherix Provides Update on its New Class of Organogold Antibiotics

05 January 2017
Trethera Corporation and Nanotherapeutics Sign Exclusive Worldwide Agreement for Rights to Triapine® in Hematological Malignancies

05 January 2017
Xigen’s Brimapitide, an innovative JNK inhibitor, delivers positive Phase II results in inflammatory eye disease

05 January 2017
Change of name to Touchstone Innovations plc and change of registered office

04 January 2017
Renowned Sinus Surgeon Dr. Peter-John Wormald Comments on AmpliPhi Biosciences’ Favorable Phase 1 Results of AB-SA01 in Chronic Rhinosinusitis Patients

04 January 2017
Clinical Network Services (CNS) UK Announces the Appointment of Dr Martin Moxham as Principal Regulatory Consultant